Previous studies from our group found that serum PON1 activity and concentration were significantly lower, and CCL2 concentration higher, in PAD patients compared to controls, while the combination of plasma CCL2 and PON1-related variables, discriminated controls from patient almost completely [30]. This evidence concerns the gene PON1 and peripheral arterial disease.